Brief: Oncolytics Biotech® Reports 2020 Second Quarter Financial Results And Operational Highlights
04/08/2020 21:14
Aug 4 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® REPORTS 2020 SECOND QUARTER FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* Q2 LOSS PER SHARE C$0.17
Source text for Eikon: ID:nCNW9yy6fa
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer